This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

VIVUS Announces AANP Scientific Presentations

Stocks in this article: VVUS

Presentation Title

Weight Loss and Improvements in Quality of Life Associated With Baseline Body-Mass Index in Obese and Overweight Patients Treated With Phentermine/Topiramate Extended-Release

Authors: Timothy Church, MD a; Ronette L. Kolotkin, PhD b; Santosh T. Varghese, MD c Affiliations: a Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA; bDuke University Medical Center and Obesity and Quality of Life Consulting, Durham, NC; cVIVUS, Inc., Mountain View, CA, USA


AANP 2013: American Association of Nurse Practitioners 28 th National Conference

June 19-23, 2013

The Venetian, The Palazzo, and Sands Expo and Convention Center, Las Vegas, Nevada


Poster Presentation Date:

  • Poster Presentation: Thursday, June 20, 4:00 PM to 6:00 PM; Friday, June 21, 4:00 PM to 6:00 PM; Saturday, June 22, 12:30 PM to 2:15 PM
  • Exhibit Hall Hours: Thursday, June 20, 10:45 AM to 1:00 PM; Friday, June 21, 11:00 AM to 6:00 PM; Saturday, June 22, 11:00 AM to 2:30 PM

Session Location: The Venetian, The Palazzo and Sands Expo and Convention Center, Exhibit Hall

Presentation Title

Prevention of Type 2 Diabetes Mellitus in Subjects With Prediabetes Using Phentermine and Topiramate Extended-Release for 1 Year

Authors: Miriam M. Rueger, RN, MPH, RD, CDE a; W. Timothy Garvey, MD a; Lan T. Nguyen b ; Craig A. Peterson, MS b

Affiliations: aUniversity of Alabama at Birmingham, Birmingham, AL; bVIVUS, Inc., Mountain View, CA

About Qsymia

Qsymia ® (phentermine and topiramate extended-release) capsules CIV is approved in the U.S. and is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol.

The effect of Qsymia on cardiovascular morbidity and mortality has not been established. The safety and effectiveness of Qsymia in combination with other products intended for weight loss, including prescription and over-the-counter drugs, and herbal preparations, have not been established.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs